FTCCI Excellence Award Presented to Converge Biotech Private Limited, Hyderabad in recognition of EXCELLENCE IN PRODUCT INNOVATION (MICRO AND SMALL ENTERPRISE)
Converge Biotech Private Limited, Hyderabad started by Mr. Arunkumar Bijjala in the year 2015, had more than 2 decades of experience working in reputed Pharmaceutical companies.
Launch of company is a coherent move to surge ahead and construct profound and longstanding relationships and trust amongst the multiple stakeholders including clinicians and patients.
Since its inception, Converge Biotech vehemently aims to deliver quality medicines at economical prices, especially in the realms of chronic care, enable patients to gain easy access to such medicines.
Numbnil, is an innovative product presented to treat DPN (Diabetic Peripheral Neuropathy) which is a destructive disease, where in Nerves are damaged due to high glucose levels. Withits unique composition it improves circulation acts as antioxidant and moisturizes skin, exerts neuroprotective action, and also acts as counter irritant with a pleasant odour.
Converge is progressing with an assembly of deeply experienced professionals, this inventive organization is an integral part of the 350 million USD group that has a conspicuous presence in the world of real estate and food processing and bears a clear eminence in the realms of quality and reliability.
Converge has a diversified portfolio of brands in the chronic care segment with dedicated
business verticals in Critical Care, Metabolics, Specialty & Oncology.
In recognition of their outstanding performance in product innovation, the FTCCI Excellence
Award for ‘Excellence in Product Innovation (Micro and Small Enterprise)’ is awarded to
Converge Biotech Private Limited, Hyderabad.